Suven Life Sciences’ net profit in Q3 dips 27%

Suven Life Sciences Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 530239 | NSE: SUVEN

06 Feb 2019 Evaluate

Suven Life Sciences has reported results for third quarter ended December 31, 2018.

The company has reported 27.08% fall in its net profit at Rs 25.23 crore for the quarter under review as compared to Rs 34.60 crore for the same quarter in the previous year. Total income of the company decreased by 19.27% at Rs 134.78 crore for Q3FY19 as compared Rs 166.95 crore for the corresponding quarter previous year.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Peers

Company Name	CMP
Sun Pharma. Inds.	1857.60
Dr. Reddys Labs.	1155.75
Cipla	1357.50
Lupin	2060.00
Zydus Lifesciences	1109.10
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.